KRKA, d.d., Novo Mesto (secondary packaging, batch control and batch release) / KRKA, d.d., Novo Mesto (manufacturing 'in bulk', primary and secondary packaging) / KRKA, d.d., Novo Mesto (batch control (physical and chemical control methods))
UkraineAll drugs from this manufacturer
-
The drug is used to treat infections caused by susceptible bacteria, specifically lower and upper respiratory tract infections (bronchitis, pneumonia, tonsillitis, pharyngitis), otitis, skin infections, as well as mycobacterial infections.
Dosage form: suspension, oral, powder for oral suspension
Active substance Dosage clarithromycin 250 mg/5 ml ATC: J01FA09